Cargando…
Forecasting Diabetes Prevalence in California: A Microsimulation
INTRODUCTION: Setting a goal for controlling type 2 diabetes is important for planning health interventions. The purpose of this study was to explore what may be a feasible goal for type 2 diabetes prevention in California. METHODS: We used the UCLA Health Forecasting Tool, a microsimulation model t...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136987/ https://www.ncbi.nlm.nih.gov/pubmed/21672404 |
_version_ | 1782208255729074176 |
---|---|
author | Shi, Lu van Meijgaard, Jeroen Fielding, Jonathan |
author_facet | Shi, Lu van Meijgaard, Jeroen Fielding, Jonathan |
author_sort | Shi, Lu |
collection | PubMed |
description | INTRODUCTION: Setting a goal for controlling type 2 diabetes is important for planning health interventions. The purpose of this study was to explore what may be a feasible goal for type 2 diabetes prevention in California. METHODS: We used the UCLA Health Forecasting Tool, a microsimulation model that simulates individual life courses in the population, to forecast the prevalence of type 2 diabetes in California's adult population in 2020. The first scenario assumes no further increases in average body mass index (BMI) for cohorts entering adolescence after 2003. The second scenario assumes a gradual BMI decrease for children entering adolescence after 2010. The third scenario builds on the second by extending the same BMI decrease to people aged 12 to 65 years. The fourth scenario builds on the third by eliminating racial/ethnic disparities in physical activity. RESULTS: We found the predicted diabetes prevalence of the first, second, third, and fourth scenarios in 2020 to be 9.93%, 9.91%, 9.76%, and 9.77%, respectively. We found obesity prevalence for type 2 diabetes patients in 2020 to be 34.2%, 34.0%, 25.7%, and 25.6% for the 4 scenarios. Life expectancy in the third (80.56 y) and fourth (80.94 y) scenarios compared favorably with that of the first (80.32 y) and second (80.32 y) scenarios. CONCLUSION: For the next 10 years, behavioral risk factor modifications are more likely to affect obesity prevalence and life expectancy in the general population and obesity prevalence among diabetic patients than to alter type 2 diabetes prevalence in the general population. We suggest setting more specific goals for reducing the prevalence of diabetes, such as reducing obesity-related diabetes complications, which may be more feasible and easier to evaluate than the omnibus goal of lowering overall type 2 diabetes prevalence by 2020. |
format | Online Article Text |
id | pubmed-3136987 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-31369872011-08-02 Forecasting Diabetes Prevalence in California: A Microsimulation Shi, Lu van Meijgaard, Jeroen Fielding, Jonathan Prev Chronic Dis Original Research INTRODUCTION: Setting a goal for controlling type 2 diabetes is important for planning health interventions. The purpose of this study was to explore what may be a feasible goal for type 2 diabetes prevention in California. METHODS: We used the UCLA Health Forecasting Tool, a microsimulation model that simulates individual life courses in the population, to forecast the prevalence of type 2 diabetes in California's adult population in 2020. The first scenario assumes no further increases in average body mass index (BMI) for cohorts entering adolescence after 2003. The second scenario assumes a gradual BMI decrease for children entering adolescence after 2010. The third scenario builds on the second by extending the same BMI decrease to people aged 12 to 65 years. The fourth scenario builds on the third by eliminating racial/ethnic disparities in physical activity. RESULTS: We found the predicted diabetes prevalence of the first, second, third, and fourth scenarios in 2020 to be 9.93%, 9.91%, 9.76%, and 9.77%, respectively. We found obesity prevalence for type 2 diabetes patients in 2020 to be 34.2%, 34.0%, 25.7%, and 25.6% for the 4 scenarios. Life expectancy in the third (80.56 y) and fourth (80.94 y) scenarios compared favorably with that of the first (80.32 y) and second (80.32 y) scenarios. CONCLUSION: For the next 10 years, behavioral risk factor modifications are more likely to affect obesity prevalence and life expectancy in the general population and obesity prevalence among diabetic patients than to alter type 2 diabetes prevalence in the general population. We suggest setting more specific goals for reducing the prevalence of diabetes, such as reducing obesity-related diabetes complications, which may be more feasible and easier to evaluate than the omnibus goal of lowering overall type 2 diabetes prevalence by 2020. Centers for Disease Control and Prevention 2011-06-15 /pmc/articles/PMC3136987/ /pubmed/21672404 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Original Research Shi, Lu van Meijgaard, Jeroen Fielding, Jonathan Forecasting Diabetes Prevalence in California: A Microsimulation |
title | Forecasting Diabetes Prevalence in California: A Microsimulation |
title_full | Forecasting Diabetes Prevalence in California: A Microsimulation |
title_fullStr | Forecasting Diabetes Prevalence in California: A Microsimulation |
title_full_unstemmed | Forecasting Diabetes Prevalence in California: A Microsimulation |
title_short | Forecasting Diabetes Prevalence in California: A Microsimulation |
title_sort | forecasting diabetes prevalence in california: a microsimulation |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136987/ https://www.ncbi.nlm.nih.gov/pubmed/21672404 |
work_keys_str_mv | AT shilu forecastingdiabetesprevalenceincaliforniaamicrosimulation AT vanmeijgaardjeroen forecastingdiabetesprevalenceincaliforniaamicrosimulation AT fieldingjonathan forecastingdiabetesprevalenceincaliforniaamicrosimulation |